Per Diem Admin/Clin Care Partner- 3F Peds/Onc

Written by lmorrell - - Comments Off on Per Diem Admin/Clin Care Partner- 3F Peds/Onc
UCLA Health
Published
June 23, 2022
Location
Los Angeles, California
Category
Other  
Job Type
PRN  

Description

Skip to content

 

 

Per Diem Admin/Clin Care Partner- 3F Peds/Onc

Work Location
Los Angeles,CA

Job #25937

Work Hours
11.5 hr night shifts including weekends and holidays

Employment Type
per diem

Duration
Indefinite

Salary Range
$27.99 – $27.99 Hourly

Posted Date
June 23, 2022

 

 

You can use your expertise, compassion, and kindness to transform the patient experience. When you join UCLA Health as a nurse, you’ll deliver leading-edge care as you build an exceptional career with a health system that’s consistently ranked among the best in the country.

 

  • JOB DUTIES

  • JOB QUALIFICATIONS

Responsibilities

Performs basic patient care skills, follows infection control practices, positions, transfers and transports patients, takes vital signs, collects specimens, accurately observes, reports and charts, performs range of motion and assists with feedings, self-care activities and elimination needs.  Additional duties include customer relations, area coordination, patient record maintenance, office/unit operations, automated data maintenance, (verifying, recording, posting and filing informational materials via automated/manual systems). Training of clerical staff, and performing other duties as required.r description  here.

Rene

RENE

If you want to grow professionally, this is the right place for you.

Era

ERA

We are family here. We support each other. We collect together.

Elizabeth

ELIZABETH

It’s so diverse and inclusive here. There’s always the opportunity to share your thoughts. It's a place where you feel you belong.

UCAN

SEE WHAT WE'RE UP TO

Facebook
Linked In
Instagram

 

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok

Related Jobs

Comments are closed.